Knowledge, Attitudes, and Practices Regarding Meningococcal B Vaccination Since the 2015 Recommendation: A Review

Oscar Herrera-Restrepo1, Diana E Clements1, Tosin Olaiya1

  • 1US Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, Pennsylvania.

Summary

Meningococcal vaccination schedules need updates. Key stakeholders show knowledge gaps about invasive meningococcal disease (IMD) and serogroup B (MenB) vaccines, hindering effective adolescent immunization.